KEGG: dre:541403
UniGene: Dr.79167
Optimal storage and handling of Recombinant Danio rerio UPF0458 protein C7orf42 homolog requires careful consideration of temperature, buffer composition, and aliquoting strategies to maintain protein stability and activity. The recommended protocol includes:
| Storage Parameter | Recommended Condition | Notes |
|---|---|---|
| Long-term storage | -20°C to -80°C | Aliquoting necessary for multiple use |
| Working storage | 4°C | For up to one week |
| Storage buffer | Tris/PBS-based buffer, pH 8.0 with 6% Trehalose | For lyophilized form |
| Reconstitution | Deionized sterile water to 0.1-1.0 mg/mL | Brief centrifugation prior to opening recommended |
| Cryoprotectant | 5-50% glycerol (final concentration) | Default recommendation is 50% |
Repeated freeze-thaw cycles should be strictly avoided as they can cause protein degradation and loss of activity . Prior to reconstitution, the vial should be briefly centrifuged to bring contents to the bottom. For long-term storage after reconstitution, adding glycerol as a cryoprotectant and dividing into single-use aliquots is essential to maintain protein integrity .
Incorporating this recombinant protein into zebrafish developmental studies requires careful experimental design that leverages the unique advantages of the zebrafish model system. The transparent nature of zebrafish embryos allows for direct visualization of protein interactions when using fluorescently tagged versions of the protein .
A methodological approach includes:
Microinjection technique: The recombinant protein can be microinjected into one-cell stage zebrafish embryos using calibrated needles (typically 0.5-1 nL volume) with protein concentrations ranging from 50-200 ng/μL depending on experimental requirements .
Developmental timing considerations: Since zebrafish embryos develop rapidly outside the mother's body, protein introduction should be timed according to the developmental stage of interest. The protein should be prepared in a physiologically compatible buffer to prevent toxicity to embryos .
Co-localization studies: The recombinant protein can be used alongside fluorescent markers to track its distribution and interaction partners during development. This approach is particularly valuable for understanding the protein's role in specific developmental processes .
Comparative analysis with morpholino knockdown: To validate functional studies, researchers should compare protein overexpression effects with targeted knockdown using antisense morpholinos against the endogenous zgc:103561 gene .
The zebrafish model is particularly advantageous for these studies due to its rapid development, optical transparency, and genetic tractability, allowing researchers to observe the effects of the recombinant protein on developmental processes in real-time .
Investigating protein-protein interactions involving Recombinant Danio rerio UPF0458 protein C7orf42 homolog requires a multi-faceted approach that combines in vitro and in vivo techniques. The following methodological framework is recommended:
Co-immunoprecipitation (Co-IP):
Use anti-His antibodies to pull down the recombinant protein from lysates
Western blot analysis with antibodies against suspected interaction partners
Include appropriate negative controls (non-specific IgG and lysates from cells not expressing the protein)
Recommended lysis buffer: 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, with protease inhibitors
Proximity Ligation Assay (PLA):
For detecting interactions in fixed zebrafish tissue sections or cells
Requires specific antibodies against both the His-tag and the putative interacting protein
Signal amplification allows detection of low-abundance interactions
Yeast Two-Hybrid Screening:
Clone the full-length protein or specific domains into appropriate bait vectors
Screen against zebrafish cDNA libraries to identify novel interaction partners
Confirm interactions using reciprocal bait-prey configurations
Bioluminescence Resonance Energy Transfer (BRET):
Generate fusion constructs with luciferase and fluorescent proteins
Monitor energy transfer in live cells as evidence of protein proximity
Calculate BRET ratios to quantify interaction strength
For membrane proteins like TMEM248, detergent selection is critical for maintaining native conformation during extraction. A comparison of detergent effectiveness is presented in the following table:
| Detergent | Concentration | Extraction Efficiency | Preservation of Interactions |
|---|---|---|---|
| Digitonin | 1% | Moderate | Excellent |
| DDM | 0.5-1% | Good | Good |
| Triton X-100 | 0.5-1% | Excellent | Moderate |
| CHAPS | 0.5-1% | Good | Good |
The choice of detergent should be optimized based on the specific experimental goals and the nature of the suspected interaction partners .
Site-directed mutagenesis represents a powerful approach for elucidating the structure-function relationship of the UPF0458 protein C7orf42 homolog. Based on sequence analysis and predicted structural features, several key regions and residues can be targeted:
Transmembrane domain modifications:
The hydrophobic regions (residues 12-34, 231-253, and 267-289) predicted to span the membrane can be mutated to assess their role in protein localization and function
Substitution of hydrophobic residues with charged amino acids (e.g., leucine to arginine) can disrupt membrane insertion
Circular dichroism spectroscopy can confirm changes in secondary structure following mutations
Conserved motif analysis:
Sequence alignment across species reveals several conserved motifs, particularly in the 103-125 and 187-210 regions
Alanine scanning mutagenesis of these regions can identify critical residues for function
Point mutations should be introduced using PCR-based techniques with appropriate primers containing the desired mutations
Post-translational modification sites:
Bioinformatic analysis predicts potential phosphorylation sites at Ser-92, Thr-94, and Ser-97
These residues can be mutated to phosphomimetic (S/T→D/E) or phospho-null (S/T→A) variants
Functional consequences can be assessed through cellular localization studies and protein interaction assays
The following table outlines a systematic mutagenesis strategy:
| Domain/Motif | Target Residues | Mutation Type | Functional Analysis Method |
|---|---|---|---|
| TM1 | L19, F24, I26 | L→R, F→R, I→D | Membrane localization assay |
| TM2 | F241, V244, M247 | F→R, V→E, M→K | Protein stability assessment |
| TM3 | F271, L275, V282 | F→R, L→D, V→E | Trafficking analysis |
| Conserved motif 1 | R107, N110, T115 | R→A, N→A, T→A | Co-IP with known partners |
| Conserved motif 2 | W194, Y197, K203 | W→A, Y→A, K→A | Functional rescue assay |
| Phosphorylation sites | S92, T94, S97 | S/T→D (mimetic) S/T→A (null) | Phosphorylation-dependent binding |
After generating the mutants, they should be expressed and purified following the same protocol as the wild-type protein, and their functional properties should be comprehensively characterized and compared to the wild-type protein .
Despite the advantages of zebrafish models for studying the UPF0458 protein C7orf42 homolog, several significant challenges and limitations must be considered when designing and interpreting experiments:
Functional redundancy challenges:
Zebrafish genome duplication events may have created paralogs with overlapping functions
Complete loss-of-function phenotypes may be masked by compensatory mechanisms
Solution approach: Employ CRISPR-Cas9 to generate multiple gene knockouts simultaneously and perform comprehensive paralog expression analysis
Protein expression and localization limitations:
Developmental timing considerations:
The rapid development of zebrafish (embryo to larvae in 72 hours) creates challenges for temporal protein function studies
Expression patterns may change dramatically across developmental stages
Solution approach: Implement inducible expression systems (e.g., heat shock promoters or Gal4/UAS systems) for temporal control
Technical challenges in membrane protein analysis:
Detergent-based extraction methods may disrupt native protein conformation and interactions
Hydrophobic nature complicates structural studies
Solution approach: Use mild detergents and native-like membrane environments (nanodiscs or liposomes) for functional studies
A comparison of current methodological approaches and their limitations is presented below:
| Method | Application | Limitations | Potential Solutions |
|---|---|---|---|
| Morpholino knockdown | Transient loss-of-function | Off-target effects, limited to early development | Use multiple morpholinos, include rescue controls |
| CRISPR-Cas9 knockout | Permanent gene disruption | Potential compensation, mosaic F0 phenotypes | Generate stable lines, analyze multiple founders |
| Recombinant protein injection | Gain-of-function, rescue | Protein stability, delivery efficiency | Optimize buffer conditions, use tissue-specific promoters |
| Live imaging of tagged protein | Localization studies | Tag interference with function | Use small tags, validate with untagged controls |
| In vitro binding assays | Interaction studies | Artificial conditions | Validate with in vivo methods |
Addressing these challenges requires combining multiple complementary approaches and careful experimental design with appropriate controls to distinguish between direct and indirect effects of protein manipulation .
The UPF0458 protein C7orf42 homolog can be studied in zebrafish development and disease models using a comprehensive methodological framework that combines genetic, molecular, and imaging approaches:
Genetic manipulation strategies:
CRISPR-Cas9 genome editing: Generate precise mutations or complete knockouts of zgc:103561
Transgenic overexpression: Create lines expressing wild-type or mutant versions under tissue-specific promoters
High-resolution phenotypic analysis:
Light sheet microscopy: For real-time imaging of protein dynamics during development
Transgenic reporter lines: To visualize affected tissues and pathways
Disease modeling applications:
Chemical induction models: Test protein function under stress conditions
Transplantation assays: For cell autonomy studies
Molecular and biochemical techniques:
The following table presents a systematic workflow for investigating protein function in disease models:
| Disease Model | Genetic Approach | Phenotypic Analysis | Molecular Analysis | Expected Timeframe |
|---|---|---|---|---|
| Developmental disorders | Knockout/knockdown | Morphology scoring, organogenesis assessment | RNA-seq at key stages | 1-14 dpf |
| Neurological function | Forebrain-specific expression | Behavioral testing, calcium imaging | Electrophysiology, neurotransmitter analysis | 3-30 dpf |
| Vascular defects | Endothelial-specific manipulation | Vessel formation imaging | Flow dynamics, permeability assays | 1-5 dpf |
| Regeneration models | Inducible expression | Fin/heart regeneration assessment | Proliferation markers, wound healing genes | 3-21 dpa |
By integrating these approaches, researchers can develop a comprehensive understanding of the UPF0458 protein C7orf42 homolog's role in normal development and disease conditions, leveraging the unique advantages of the zebrafish model system .
Working with Recombinant Danio rerio UPF0458 protein presents several technical challenges that require specific troubleshooting approaches:
Protein solubility and aggregation issues:
Challenge: The transmembrane domains of UPF0458 protein can cause aggregation during expression and purification.
Solution: Optimize expression conditions using lower induction temperatures (16-20°C) and include solubility enhancers like 0.1% Triton X-100 or 0.5% CHAPS in purification buffers. Consider using fusion partners like MBP (maltose-binding protein) to enhance solubility .
Protein degradation during storage and handling:
Inconsistent activity in functional assays:
Non-specific binding in interaction studies:
The following table provides a comprehensive troubleshooting guide for common issues:
| Problem | Possible Causes | Diagnostic Approach | Solution |
|---|---|---|---|
| Low protein yield | Poor expression, insolubility | SDS-PAGE analysis of total vs. soluble fractions | Optimize expression temperature (16-20°C), use solubility tags |
| Multiple bands on Western blot | Degradation, non-specific antibody binding | Time-course stability test, alternative antibodies | Add protease inhibitors, optimize antibody dilution |
| Loss of activity during storage | Freeze-thaw damage, oxidation | Activity assay before/after storage | Single-use aliquots, add reducing agents (DTT 1mM) |
| Precipitation upon buffer exchange | Buffer incompatibility | Systematic buffer screening | Gradual dialysis, include stabilizers (10% glycerol) |
| Poor reproducibility in binding assays | Variable protein conformation | Circular dichroism analysis | Standardize purification protocol, verify proper folding |
When troubleshooting, it's essential to change only one parameter at a time and document all conditions thoroughly to identify critical factors affecting protein behavior .
Designing appropriate controls is crucial for experiments involving Recombinant Danio rerio UPF0458 protein C7orf42 homolog to ensure reliable and interpretable results. A systematic control strategy should include:
Protein-specific controls:
Denatured protein control: Heat-treated (95°C for 10 minutes) protein sample to serve as a negative control for structure-dependent functions
Tag-only control: Express and purify the His-tag portion alone to distinguish tag-mediated effects from protein-specific effects
Concentration-matched BSA control: Use equal concentrations of bovine serum albumin as a non-specific protein control
Genetic and functional controls:
Rescue experiments: When knocking down endogenous protein, confirm specificity by rescuing with recombinant protein resistant to knockdown
Inactive mutant control: Create a predicted non-functional mutant (e.g., by mutating conserved residues) as a negative control
Related protein control: Use a closely related but functionally distinct protein to demonstrate specificity
Experimental system controls:
Buffer-only controls: Include matched buffer components without protein to control for buffer effects
Untreated/wild-type controls: Maintain parallel wild-type samples without any protein treatment
Time-matched controls: Process control samples at identical timepoints to account for time-dependent variables
Validation controls:
Antibody validation: Confirm antibody specificity using western blots of wild-type vs. knockout samples
Cross-species validation: Test conserved function in multiple model systems when possible
Technical replicates: Perform at least three independent experimental replicates with freshly prepared protein
The following decision matrix helps determine appropriate controls based on experiment type:
| Experiment Type | Essential Controls | Recommended Additional Controls | Control Analysis Method |
|---|---|---|---|
| Binding assays | No-protein control, BSA control, His-tag only | Dose-response series, Competitor proteins | Quantitative comparison to baseline |
| Morpholino studies | Mismatch morpholino, Rescue with recombinant protein | Second non-overlapping morpholino, Cross-species rescue | Statistical comparison of phenotype penetrance |
| Localization studies | Untransfected cells, Tag-only expression | Subcellular marker co-localization, Mutant localization | Pearson's correlation coefficient |
| Functional assays | Buffer control, Inactive mutant | Dose-response, Time-course | ANOVA with post-hoc analysis |
| In vivo studies | Sham injection, Irrelevant protein | Genetic knockout validation, Tissue-specific rescue | Blinded scoring of phenotypes |
By implementing these control strategies, researchers can distinguish specific effects of the recombinant protein from experimental artifacts and establish the biological relevance of their findings .
The study of UPF0458 protein C7orf42 homolog in zebrafish presents several promising research frontiers that leverage technological innovations and biological insights:
Single-cell transcriptomics integration:
CRISPR screening applications:
Organoid and ex vivo systems:
Cross-species functional conservation studies:
Disease modeling applications:
The following table outlines specific research opportunities with associated methodological approaches:
| Research Direction | Key Technologies | Expected Outcomes | Potential Impact |
|---|---|---|---|
| Membrane protein structural biology | Cryo-EM, AlphaFold2 predictions | 3D structure of UPF0458 protein | Structure-guided drug design |
| Developmental signaling role | Light-sheet microscopy, optogenetics | Dynamic protein function map | Insights into developmental disorders |
| Chemical biology | PROTAC technology, photocrosslinking | Targeted protein degradation tools | Therapeutic development |
| Systems biology | Phosphoproteomics, interactome mapping | Integration into signaling networks | Pathway-level understanding |
| Regenerative medicine | Lineage tracing, trauma models | Role in tissue regeneration | Therapeutic applications |
These emerging research directions will benefit from the continued refinement of zebrafish genetic tools and imaging technologies, allowing unprecedented insights into the biological functions of this poorly characterized protein .
Computational approaches offer powerful tools for elucidating the structure and function of the UPF0458 protein C7orf42 homolog, particularly given the challenges of experimental characterization of membrane proteins. A multi-faceted computational strategy includes:
Advanced structural prediction methods:
AlphaFold2 and RoseTTAFold: Generate high-confidence structural models of the full-length protein
Prediction accuracy: Typically >90% for transmembrane topology prediction
Validation: Compare with experimental data from CD spectroscopy or limited proteolysis
Molecular dynamics simulations: Model protein behavior in membrane environments
Evolutionary analysis approaches:
Sequence conservation mapping: Identify functionally important residues across species
Conservation scoring: ConSurf or Rate4Site algorithms
Visualization: Map conservation onto structural models to identify functional surfaces
Coevolution analysis: Detect coevolving residue pairs suggesting structural contacts
Network-based functional prediction:
Protein-protein interaction network analysis: Predict functional associations
Data integration: Combine experimental interactome data with predictive algorithms
Clustering: Identify functional modules containing UPF0458 protein
Gene co-expression networks: Identify co-regulated genes across developmental stages
Machine learning approaches:
Function prediction: Train ML models on proteins with known functions to predict UPF0458 roles
Features: Sequence motifs, structural properties, expression patterns
Validation: Cross-validation against partial experimental data
Binding site prediction: Identify potential ligand binding pockets
Methods: Geometric analysis, conservation mapping, fragment docking
Output: Ranked list of potential binding sites with confidence scores
The following table summarizes computational methods and their applications:
| Computational Approach | Software/Resources | Key Parameters | Expected Insights |
|---|---|---|---|
| Structural prediction | AlphaFold2, RoseTTAFold | MSA depth >30 sequences | Full 3D structure, confidence per residue |
| Molecular dynamics | GROMACS, NAMD, Amber | 100-500 ns, CHARMM36 force field | Membrane interactions, conformational changes |
| Sequence analysis | HMMER, BLAST, ConSurf | E-value cutoff 1e-10 | Functional domains, conserved motifs |
| Coevolutionary analysis | EVcouplings, GREMLIN | Min. 500 diverse sequences | Contact map validation, interaction interfaces |
| Network analysis | STRING, Cytoscape | Confidence score >0.7 | Functional associations, pathway membership |
| Drug binding prediction | AutoDock, Rosetta | Energy scoring, ensemble docking | Potential binding pockets, drug interactions |
Integration of these computational approaches with targeted experimental validation creates a powerful framework for understanding this poorly characterized protein, potentially revealing novel functions and therapeutic opportunities .
Researchers working with Recombinant Danio rerio UPF0458 protein C7orf42 homolog (zgc:103561) should consider several key principles and practical aspects to maximize experimental success and meaningful data generation:
Protein handling and stability considerations:
Experimental design principles:
Technical recommendations:
Functional characterization strategy:
Future research considerations: